Section one: Contracting authority
one.1) Name and addresses
NHS Wales Shared Services Partnership on behalf of Cardiff and Vale University Local Health Board
2nd Floor, Woodland House, Maes-Y-Coed Rd
Cardiff
CF14 4TT
Telephone
+44 292136446
Country
United Kingdom
NUTS code
UK - United Kingdom
Internet address(es)
Main address
http://nwssp.nhs.wales/ourservices/procurement-services/
Buyer's address
https://www.sell2wales.gov.wales/search/Search_AuthProfile.aspx?ID=AA0221
one.2) Information about joint procurement
The contract is awarded by a central purchasing body
one.4) Type of the contracting authority
Body governed by public law
one.5) Main activity
Health
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
Next Generation Sequencing Panel for Analysis of Somatic (Solid Tumour and Haemato-oncology) Samples
Reference number
CAV-OJEU-PROJECT45611
two.1.2) Main CPV code
- 33696500 - Laboratory reagents
two.1.3) Type of contract
Supplies
two.1.4) Short description
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) on behalf of Cardiff and Vale University Health Board are looking to procurement a somatic NGS testing platform with a single workflow for both DNA and RNA library preparation. It must be a targeted panel of at least 500 genes for the DNA component and 50 genes for the RNA component which are of clinical relevance to comprehensive cancer genomic profiling (including both current and future clinically actionable genes and those associated with clinical trials).
two.1.6) Information about lots
This contract is divided into lots: No
two.1.7) Total value of the procurement (excluding VAT)
Value excluding VAT: £10,768,696.40
two.2) Description
two.2.2) Additional CPV code(s)
- 33696500 - Laboratory reagents
two.2.3) Place of performance
NUTS codes
- UKL22 - Cardiff and Vale of Glamorgan
Main site or place of performance
All Wales Medical Genomics Laboratory
Cardiff & Vale University Health Board
University Hospital of Wales
Heath Park
Cardiff
CF14 4XW
two.2.4) Description of the procurement
The All Wales Medical Genomics Laboratory (AWMGL) recently received an uplift in funding to enable the delivery of equitable testing for patients in Wales to patients in England who are eligible for tests detailed in the Genomics England National Genomics Test Directory for Cancer, thus, supporting AWMGL to work with Welsh clinicians to align services to the Test Directory. To enable successful alignment it is essential that the laboratory expands their services that are offered to those that are indicated as essential services in the Genomics England National Genomics Test Directory for Cancer 2020/2021 (https://www.england.nhs.uk/publication/national-genomic-test-directories/).
To meet the service needs, AWMGL are looking to purchase a new DNA and RNA based single targeted somatic testing panel of at least 500 genes of clinical relevance to comprehensive cancer genomic profiling (including both current and future clinically actionable genes and those associated with clinical trials).
two.2.5) Award criteria
Quality criterion - Name: Quality / Weighting: 60
Price - Weighting: 40
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
Section four. Procedure
four.1) Description
four.1.1) Type of procedure
Open procedure
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: Yes
four.2) Administrative information
four.2.1) Previous publication concerning this procedure
Notice number: 2020/S 203-494848
Section five. Award of contract
A contract/lot is awarded: Yes
five.2) Award of contract
five.2.1) Date of conclusion of the contract
16 March 2021
five.2.2) Information about tenders
Number of tenders received: 2
Number of tenders received from SMEs: 0
Number of tenders received from tenderers from other EU Member States: 2
Number of tenders received from tenderers from non-EU Member States: 0
Number of tenders received by electronic means: 2
The contract has been awarded to a group of economic operators: No
five.2.3) Name and address of the contractor
Illumina Cambridge Ltd
Illumina Centre, 19 Granta Park, Great Abington
Cambridge
CB216DF
Telephone
+44 1223824908
Country
United Kingdom
NUTS code
- UKH12 - Cambridgeshire CC
The contractor is an SME
No
five.2.4) Information on value of contract/lot (excluding VAT)
Total value of the contract/lot: £10,768,696.40
Section six. Complementary information
six.3) Additional information
1. The Contracting Authority reserves the right to award the contract in whole, in part or annul the tendering process and not award any contract.
2. Bidders should note that they will be required to enter into terms and conditions of contract as set out in the ITT and that save for matters of clarification or consistency the Contracting Authority will not negotiate the terms.
3. The Contracting Authority will not accept completed ITT's after the stated closing date.
4. All documents to be priced (where applicable) in sterling and all payments made in sterling.
5. All tender costs and liabilities incurred by bidders shall be the sole responsibility of the bidders.
6. Prospective suppliers should note that NHS Shared Services Partnership - Procurement Services is acting on behalf of Cardiff and Vale ULHB
7. Bidders wishing to participate should visit the Bravo e-tenderwales portal and access the itt_83892 for all tender documentation.
(WA Ref:110589)
six.4) Procedures for review
six.4.1) Review body
High Court
Royal Courts of Justice, The Strand
London
Country
United Kingdom
six.4.3) Review procedure
Precise information on deadline(s) for review procedures
NHS Wales Shared Services Partnership on behalf of Cardiff and Vale University Local Health Board will allow a minimum 10 calendar day standstill period between notifying the award decision and awarding the contract.
Unsuccessful tenderers and applicants are entitled to receive reasons for the decision, including the characteristics and relative advantages of the winning bid and the reasons why the tenderer/applicant was unsuccessful. Should additional information be required it should be requested of the addressee in section I.1. Aggrieved parties who have been harmed or are at risk of harm by breach of the procurement rules have the right to take action in the High Court (England and Wales). Any such action is subject to strict time limits in accordance with the Public Contracts (Amendments) Regulations 2015.